Korro Bio (KRRO) Share-based Compensation (2018 - 2026)
Korro Bio (KRRO) posted Share-based Compensation of $2.7 million for Q2 2026, up 35.3% from $2 million a year earlier but down 1.0% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Share-based Compensation (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Korro Bio was $9.33 million, up 46.0% year-over-year; for FY2025, it came in at $7.66 million, up 71.6% from FY2024.
- Annual Share-based Compensation has increased for three consecutive years, though with a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
- In prior years, Korro Bio's Share-based Compensation was $4.46 million in FY2024 (+87.4%), $2.38 million in FY2023 (+108.9%), $1.14 million in FY2022 (-94.8%) and $21.75 million in FY2021 (+117.9%).
- Quarterly Share-based Compensation has run from a low of -$14.29 million in Q4 2022 to a high of $5.89 million in Q3 2021 over five years.
- On a year-over-year basis, Share-based Compensation has increased in each of the last ten quarters, with growth averaging 77.8% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2024, with growth of 215.1%; the weakest was Q1 2023, with a decline of 93.4%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.73 million (Q1 2026), $2.07 million (Q4 2025) and $1.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - | 2.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 967,000.00 |
| Mar 31, 2024 | 865,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 404,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Dec 31, 2022 | -14.29 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | 4.56 Mn |
| Mar 31, 2022 | 5.27 Mn |
| Dec 31, 2021 | 5.16 Mn |
| Sep 30, 2021 | 5.89 Mn |
API Access
Korro Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();